sz300347
泰格医药研报 已收录392篇研报
![公司信息更新报告:业绩稳健增长,一体化服务能力持续增强](https://img.ulapia.com/thumbnails/stock_research/20231117/H3_AP202311171611260105_1.jpg!thumbnail_180)
![泰格医药2023Q3业绩点评:主业延续高增,看好国际化](https://img.ulapia.com/thumbnails/stock_research/20231107/H3_AP202311071609248451_1.jpg!thumbnail_180)
![2023年三季报点评:业绩符合预期,常规业务持续修复](https://img.ulapia.com/thumbnails/stock_research/20231102/H3_AP202311021607888497_1.jpg!thumbnail_180)
![Business stabilizing from late September](https://img.ulapia.com/thumbnails/stock_research/20231030/H3_AP202310301605646755_1.jpg!thumbnail_180)
招银国际
Business stabilizing from late September
页数:
5页
股票:
泰格医药(300347)
行业:
医疗服务
作者:
Jill Wu
Benchen Huang
发布日期:2023-10-30
报告全文
![公司信息更新报告:业绩环比持续改善,常规业务增速稳健](https://img.ulapia.com/thumbnails/stock_research/20230831/H3_AP202308311596906179_1.jpg!thumbnail_180)
开源证券
公司信息更新报告:业绩环比持续改善,常规业务增速稳健
页数:
4页
股票:
泰格医药(300347)
行业:
医疗服务
作者:
蔡明子
余汝意
汪晋
发布日期:2023-08-31
报告全文
![2023年中报点评:业务稳健发展,常规业务增长强劲](https://img.ulapia.com/thumbnails/stock_research/20230830/H3_AP202308301596815466_1.jpg!thumbnail_180)
![Q2呈稳步恢复态势,期待下半年持续恢复](https://img.ulapia.com/thumbnails/stock_research/20230830/H3_AP202308301596816007_1.jpg!thumbnail_180)
![非新冠业务增长迅速,国际化能力不断提升](https://img.ulapia.com/thumbnails/stock_research/20230829/H3_AP202308291596599730_1.jpg!thumbnail_180)
![Healthy growth amid challenging environment](https://img.ulapia.com/thumbnails/stock_research/20230829/H3_AP202308291596601710_1.jpg!thumbnail_180)
招银国际
Healthy growth amid challenging environment
页数:
5页
股票:
泰格医药(300347)
行业:
医疗服务
作者:
Jill Wu
Benchen Huang
发布日期:2023-08-29
报告全文
![挑战性环境下稳步发展,持续布局海外业务](https://img.ulapia.com/thumbnails/stock_research/20230828/H3_AP202308281595908027_1.jpg!thumbnail_180)